QQQ $ 444.97 $ 1.51 (0.34 %)
DIA $ 397.57 $ 4.71 (1.2 %)
SPY $ 523.27 $ 4.36 (0.84 %)
TLT $ 94.66 $ 0.93 (0.99 %)
GLD $ 203.04 $ 1.46 (0.72 %)
$ 0.0002
-- x --
-- x --
-- - --
$ 0.00 - $ 0.11
656
na
2,145
$ 0.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2022 09-30-2022 10-Q
2 08-11-2022 06-30-2022 10-Q
3 05-12-2022 03-31-2022 10-Q
4 03-17-2022 12-31-2021 10-K
5 11-12-2021 09-30-2021 10-Q
6 08-12-2021 06-30-2021 10-Q
7 05-13-2021 03-31-2021 10-Q
8 03-18-2021 12-31-2020 10-K
9 11-12-2020 09-30-2020 10-Q
10 08-13-2020 06-30-2020 10-Q
11 05-14-2020 03-31-2020 10-Q
12 03-19-2020 12-31-2019 10-K
13 11-07-2019 09-30-2019 10-Q
14 08-08-2019 06-30-2019 10-Q
15 05-09-2019 03-31-2019 10-Q
16 03-15-2019 12-31-2018 10-K
17 11-08-2018 09-30-2018 10-Q
18 08-09-2018 06-30-2018 10-Q
19 05-10-2018 03-31-2018 10-Q
20 03-16-2018 12-31-2017 10-K
21 11-08-2017 09-30-2017 10-Q
22 08-10-2017 06-30-2017 10-Q
23 05-11-2017 03-31-2017 10-Q
24 02-16-2017 12-31-2016 10-K
25 11-10-2016 09-30-2016 10-Q
26 08-11-2016 06-30-2016 10-Q
27 05-13-2016 03-31-2016 10-Q
28 03-24-2016 12-31-2015 10-K
29 11-13-2015 09-30-2015 10-Q
30 08-14-2015 06-30-2015 10-Q
31 05-15-2015 03-31-2015 10-Q
32 03-16-2015 12-31-2014 10-K
33 11-14-2014 09-30-2014 10-Q
34 08-13-2014 06-30-2014 10-Q
35 05-15-2014 03-31-2014 10-Q
36 03-31-2014 12-31-2013 10-K
37 11-14-2013 09-30-2013 10-Q
38 08-14-2013 06-30-2013 10-Q
39 05-15-2013 03-31-2013 10-Q
40 03-29-2013 12-31-2012 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nasdaq-edges-higher-neovasc-shares-jump

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.

 why-calyxt-shares-are-trading-higher-by-around-116-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, dec...

 stocks-that-hit-52-week-lows-on-tuesday

  Tuesday saw 9 companies set new 52-week lows.

 dow-tumbles-300-points-morgan-stanley-beats-q4-views

U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.

 viveve-medical-to-seek-strategic-alternatives-and-will-be-delisted-from-nasdaq-company-announced-treatment-for-female-stress-urinary-incontinence-did-not-meet-primary-endpoint

Viveve Medical, Inc. (NASDAQ: VIVE) today announced topline result from the U.S. Pivotal PURSUIT clinical trial. PURSUIT was a...

 why-applied-molecular-transport-shares-are-trading-lower-by-over-55-here-are-47-stocks-moving-in-fridays-mid-day-session

Gainers

 stocks-that-hit-52-week-lows-on-monday

  Monday saw 196 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-friday

  On Friday, 72 companies hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 89 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  OnThursday, 137 stocks made new 52-week lows.

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 70 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-friday

  On Friday, 63 stocks hit new 52-week lows.

 viveve-medical-q3-eps-059-beats-066-estimate-sales-168m-miss-170m-estimate

Viveve Medical (NASDAQ:VIVE) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.66...

 earnings-scheduled-for-november-10-2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.

 stocks-that-hit-52-week-lows-on-monday

  On Monday, 413 companies reached new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION